OTCMKTS:AVMXY

AVITA MED LTD/S (AVMXY) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free AVMXY Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $7.89
▼
$7.89
50-Day Range: $7.89
▼
$7.89
52-Week Range: $1.06
▼
$8.58

Volume: N/A
Average Volume: 183,275 shs
Market Capitalization: $651.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get AVITA MED LTD/S alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About AVITA MED LTD/S Stock (OTCMKTS:AVMXY)

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

AVMXY Stock News Headlines

April 12, 2024 | markets.businessinsider.com

Lake Street Keeps Their Buy Rating on Avita Medical (RCEL)

April 11, 2024 | marketwatch.com

Avita Medical Shares Fall 6.6% on Revised 1Q Outlook, 2024 Revenue Expectations

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 12, 2024 | msn.com

E-Smart Clinic Goes LIVE! A Lord's Mark Initiative for a Healthier India in Collaboration with Government of India

March 1, 2024 | msn.com

Max Healthcare, Aster DM, KIMS shares tank up to 8% today. Here's why

February 17, 2024 | wsj.com

Sisram Medical Ltd.

February 5, 2024 | news.yahoo.com

Avita Ontario Hospital first stop on statewide Ohio Adversity and Resilience Study tour

January 10, 2024 | msn.com

Avita Medical misses Q4,FY 23 prelim revenue estimate

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

November 23, 2023 | morningstar.com

AVITA Medical Inc AVHHL

November 21, 2023 | marketwatch.com

Avita Medical Shares Drop After 2023 Commercial Revenue Outlook Cut

November 21, 2023 | msn.com

AVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

November 11, 2023 | benzinga.com

AVITA Medical Stock (NASDAQ:RCEL), Analyst Ratings, Price Targets, Predictions

October 24, 2023 | fool.com.au

Why AVITA Medical, Bellamy's, Evolution, & Volpara shares dropped into the red today

October 2, 2023 | msn.com

Why Shares of Avita Medical Are Down Monday

September 26, 2023 | markets.businessinsider.com

Analyst Expectations for AVITA Medical's Future

September 1, 2023 | finance.yahoo.com

Q2 2023 AVITA Medical Inc Earnings Call

July 20, 2023 | msn.com

AVITA's Balancing Act: RECELL System's Promise Amid Market Uncertainties

May 14, 2023 | msn.com

Avita Medical (ASX:AVH) Price Target Increased by 5.95% to 6.05

May 12, 2023 | benzinga.com

AVITA Medical shares are trading lower after the company reported mixed Q1 financial results.

May 12, 2023 | markets.businessinsider.com

Piper Sandler Keeps Their Buy Rating on Avita Medical (RCEL)

May 12, 2023 | markets.businessinsider.com

Here's what Wall Street expects from AVITA Therapeutics's earnings report

May 2, 2023 | news.yahoo.com

Briefs: Avita medication program, Senior Spring Extravaganza, ODNR honor

March 19, 2023 | seekingalpha.com

AVITA Medical: At A Crossroads

February 26, 2023 | finance.yahoo.com

Q4 2022 AVITA Medical Inc Earnings Call

February 24, 2023 | benzinga.com

Avita Medical shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.

February 13, 2023 | finance.yahoo.com

Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer

See More Headlines

Receive AVMXY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA MED LTD/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological Products, Except Diagnostic
Sub-Industry: N/A
Current Symbol: OTCMKTS:AVMXY
CUSIP: N/A
CIK: N/A
Web: www.avitamedical.com
Phone: 661-367-9170
Fax: N/A
Employees: 55
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.50
Quick Ratio: 5.33

Sales & Book Value

Annual Sales: $5.51 million
Price / Sales: 118.31
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.26 per share
Price / Book: 30.35

Miscellaneous

Outstanding Shares: 82,620,000
Free Float: N/A
Market Cap: $651.87 million
Optionable: Not Optionable
Beta: 1.28

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Michael S. Perry (Age 60)
CEO & Director
Mr. Timothy Rooney
Chief Admin. Officer & Interim CFO
Mr. Andrew Quick
Chief Technology Officer
Ms. Erin Liberto
Chief Commercial Officer
Mr. Adam Kelliher
Consultant

Key Competitors

View All Competitors

This page (OTCMKTS:AVMXY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AVITA MED LTD/S (AVMXY) Stock Price, News & Analysis

About AVITA MED LTD/S Stock (OTCMKTS:AVMXY)

AVMXY Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info